tirzepatide fda submission An experimental weight-loss drug from Eli Lilly looks like the most promising weight-loss drug ever tested, rivaling the results of gastric bypass surgery. Retatrutide injections, designed to be taken once a week Compound Tirzepatide

Williams JA, Su HS, Bernards A, Field J, Sehgal A

Many people experience digestive issues, especially in the first few weeks as their body adjusts

PlexusDx's compounded optionsboth sublingual and injectable tirzepatideallow your provider to select the formulation most compatible with your clinical status and preference

If you have severe abdominal pain or other serious side effects while taking Mounjaro, seek emergency medical services and contact your Calibrate clinician right away

Results May Vary: Individual results vary based on age, baseline health, starting weight, lifestyle factors, consistency of use, genetic factors, current medications, and other variables

doi:10.1056/NEJMoa2301972 2